HIA
ABBV icon

HFM Investment Advisors’s AbbVie ABBV Stock Holding History

HFM Investment Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.79K Buy
27
+13
+93% +$2.8K ﹤0.01% 155
2026
Q1 		$3.04K Sell
14
-22
-61% -$4.88K ﹤0.01% 188
2025
Q4 		$8.23K Buy
36
+1
+3% +$228 ﹤0.01% 137
2025
Q3 		$8.1K Hold
35
– – ﹤0.01% 90
2025
Q2 		$6.5K Buy
35
+20
+133% +$3.72K ﹤0.01% 107
2025
Q1 		$3.14K Buy
+15
New +$2.92K ﹤0.01% 124

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

HFM Investment Advisors's ABBV Position: Q2 2026 in Review

HFM Investment Advisors increased its AbbVie (ABBV) stake by 93% in Q2 2026, buying an estimated $2.8K and bringing the position to 27 shares worth $6.79K. The position accounts for ﹤0.01% of the portfolio, ranked #155.

HFM Investment Advisors first reported a position in ABBV in Q1 2025 and has held it in 6 quarters since. The position peaked at $8.23K in Q4 2025. 4,234 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • HFM Investment Advisors held 27 shares of AbbVie worth $6.79K as of Q2 2026.
  • HFM Investment Advisors bought 13 AbbVie shares in Q2 2026, an estimated $2.8K.
  • AbbVie made up ﹤0.01% of HFM Investment Advisors's portfolio in Q2 2026, its #155 holding.
  • HFM Investment Advisors first reported a position in AbbVie in Q1 2025 and has held it in 6 quarters since.
  • HFM Investment Advisors's AbbVie position peaked at $8.23K in Q4 2025.
  • 4,234 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on HFM Investment Advisors's 13F filing for Q2 2026, filed 4 Aug 2026.